Key facts
- Notable investors include Lazio Innova.
- Status: Acquired/Merged (Operating Subsidiary).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for EUROFINS Genoma Group
- ·The full record, as it builds
Funding rounds
No funding rounds for EUROFINS Genoma Group are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About EUROFINS Genoma Group
Provider of genetic and molecular diagnostic services intended for clinical and research purposes. The company's platform offers a wide range of genetic tests across multiple specialist areas, supported by advanced molecular technologies, accredited laboratories, and expert consultation services, enabling healthcare professionals and institutions to access comprehensive diagnostic services for genetic, cytogenetic, and molecular analysis needs throughout Europe.
- Sector
- Healthcare
- HQ
- Rome, Italy
- Founded
- 1997
- Employees
- 100
- Website
- laboratoriogenoma.eu/
- Ownership
- Acquired/Merged (Operating Subsidiary)
EUROFINS Genoma Group doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in EUROFINS Genoma Group shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on EUROFINS Genoma Group in its N-PORT filings yet. We sweep new filings monthly.